Delivery Order SPE2DB22D1106-SPE2DB25FFBN2
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,068.56 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Likmez 500 mg/5 mL suspension in 200 mL quantities. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 through December 2026. The delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,993.76 to AmerisourceBergen Drug Corp for the supply of LIKMEZ 500 mg/5 mL suspension in 200 mL quantities. This firm fixed-price contract was competitively awarded without set-aside designation and is set for completion by July 24, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,050.24 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of LIKMEZ 500 MG/5 ML SUSPENSION 200ML, a pharmaceutical product, and has a completion date of January 31, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIKMEZ 500 MG/5 ML SUSPENSION 200ML, a pharmaceutical product. The award has a firm fixed price of $3,798.29 and a completion date of September 5, 2024. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,724.96 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA and carries no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,722.49 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract leveraging AmerisourceBergen's comprehensive pharmaceutical and medical supply capabilities. The work will be performed at the contractor's Corporate Office location in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,453.10 to AmerisourceBergen Drug Corp on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is classified...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,403.30 to AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, on August 4, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by August 5, 2025. The award was made through competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $438,690.30 to AmerisourceBergen Drug Corp on August 4, 2025, with a completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to support federal medical procurement needs. The contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...